Notice2022-21187
Agency Forms Undergoing Paperwork Reduction Act Review
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 30, 2022
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 189 (Friday, September 30, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 189 (Friday, September 30, 2022)]
[Notices]
[Pages 59429-59430]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-21187]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-22-1150]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Generic Clearance for Lyme and other
Tickborne Diseases Knowledge, Attitudes, and Practices Surveys'' to the
Office of Management and budget (OMB) for review and approval. CDC
previously published a ``Proposed Data Collection Submitted for Public
Comment and Recommendations'' notice on March 18, 2022 to obtain
comments from the public and affected agencies. CDC did not receive
comments related to the previous notice. This notice serves to allow an
additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Lyme and other Tickborne Diseases Knowledge, Attitudes, and
Practices Surveys (OMB Control Number 0920-1150, Exp. 9/30/2022)--
Revision--National Center for Emerging and Zoonotic Infectious Diseases
(NCEZID), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and Prevention (CDC) Division of
Vector-Borne Diseases (DVBD) and other programs working on tickborne
diseases (TBDs) are requesting a Revision to a previously approved
generic clearance to conduct TBD prevention studies to include
knowledge, attitudes, and practices (KAP) surveys regarding ticks and
tickborne diseases (TBDs) among residents and businesses offering pest
control services in Lyme disease endemic areas of the United States.
The data collection for which approval is sought will allow DVBD to use
survey results to inform implementation of future TBD prevention
interventions. The Revision involves a broadening of the secondary
target population from owners and employees of pest control companies
to stakeholders of local entities affected by TBDs (e.g., leaders in
local public health or local government; owners or employees of pest
control companies, landscaping companies, or other at-risk occupations;
non-governmental organizations serving at-risk populations; and/or
clinicians serving at-risk populations).
TBDs are a substantial and growing public health problem in the
United States. From 2004-2016, over 490,000 cases of TBDs were reported
to CDC, including cases of anaplasmosis, babesiosis, ehrlichiosis, Lyme
disease, Rocky Mountain spotted fever, and tularemia. Lyme disease
accounted for 82% of all TBDs, with over 400,000 cases reported during
this time period. Recent studies estimate nearly 500,000 cases of Lyme
disease are diagnosed annually in the United States. In addition,
several novel tickborne pathogens have recently been found to cause
human disease in the United States. Factors driving the emergence of
TBDs are not well defined and current prevention methods have been
insufficient to curb the increase in cases. Data is lacking on how
often certain prevention measures are used by individuals at risk, as
well as what the barriers to using certain prevention measure are.
The primary target population for these data collections are
individuals and their household members who are at risk for TBDs
associated with I.scapularis ticks and who may be exposed to these
ticks residentially, recreationally, and/or occupationally. The
secondary target population includes stakeholders of local entities
affected by TBDs (e.g., leaders in local public health or local
government; owners or employees of pest control companies, landscaping
companies, or other at-risk occupations; non-governmental organizations
serving at-risk populations; and/or clinicians serving at-risk
populations) in areas where I. scapularis ticks transmit diseases to
humans. Specifically, these target populations include those residing
or working in the 15 highest incidence states for Lyme disease (CT, DE,
ME, MD, MA, MN, NH, NJ, NY, PA, RI, VT, VA, WI and WV). We anticipate
conducting one to two surveys per year, for a maximum of six surveys
conducted over a three-year period. Depending on the survey, we aim to
enroll 500-10,000 participants per study. It is expected that we will
need to target recruitment to about twice as many people as we intend
to enroll. Surveys may be conducted daily, weekly, monthly, or bi-
monthly per participant for a defined period (whether by phone or web
survey), depending on the survey or study. The surveys will range in
duration from approximately 5-30 minutes. Each participant may be
surveyed 1-64 times in one year; this variance is due to differences in
the type of information collected for a given survey. Specific burden
estimates for each study and each information collection instrument
will be provided with each individual project submitted for OMB review.
Insights gained from KAP surveys will aid in prioritizing which
prevention methods should be evaluated in future randomized, controlled
trials and ultimately help target promotion of proven prevention
[[Page 59430]]
methods that could yield substantial reductions in TBD incidence.
CDC requests OMB approval for an estimated 98,830 annual burden
hours. There is no cost to respondents other than their time to
participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
General public, individuals or Screening instrument.... 20,000 1 15/60
households.
Consent Form............ 10,000 1 20/60
Introductory Surveys.... 10,000 1 30/60
Monthly Surveys......... 10,000 12 15/60
Final Surveys........... 10,000 1 30/60
Daily Surveys........... 10,000 60 5/60
Stakeholders of local entities Stakeholder Survey...... 1,000 1 30/60
affected by TBDs.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity,Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-21187 Filed 9-29-22; 8:45 am]
BILLING CODE 4163-18-P
</pre></body>
</html>Indexed from Federal Register on September 30, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.